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The association of antibodies against oxidized low-density lipo- of the modified lipoprotein and the process of atheroscle-
protein with atherosclerosis in hemodialysis patients. rosis [1]. Previous studies showed raised serum titer of
Background. Immune response to oxidized low-density lipo-
anti-oxidized LDL antibody in those with advanced ath-protein (oxLDL) may modulate atherogenesis. We recently
erosclerosis [2–4] and in patients with end-stage renalreported that a high titer of serum anti-oxLDL antibody was
an independent predictor of a low risk for cardiovascular death disease (ESRD) [5]. In contrast, studies in familial hyper-
in patients with end-stage renal disease (ESRD). In the present cholesterolemia [6] showed that those patients having
study, we examined a possible association between anti-oxLDL
had a myocardial infarction had a lower anti-oxidizedantibody titer and arterial wall thickness in ESRD patients.
LDL antibody titer than those who had not had a myo-Methods. The subjects were 103 ESRD patients treated with
hemodialysis. A high resolution B-mode ultrasound method was cardial infarction. We [7] found in healthy subjects that
used to measure intima-media thickness of carotid (CA-IMT) serum anti-oxidized LDL antibody titer correlated in-
and femoral arteries (FA-IMT).
versely with oxidized LDL concentration in the circula-Results. In univariate analysis, anti-oxLDL antibody showed
tion. Also, anti-oxidized LDL antibody correlated in-a significant negative correlation with FA-IMT. The inverse as-
sociation between anti-oxLDL antibody and FA-IMT remained versely with intima-media thickness of the carotid artery
significant in multiple regression analysis, including age, gen- (CA-IMT) [8] and femoral artery (FA-IMT) [9] in a
der, blood pressure, plasma lipids, smoking, C-reactive protein,
healthy population. Furthermore, in a prospective cohortcalcium-phosphate product, serum albumin, body mass index,
study [10], we recently revealed that a high titer of anti-and duration of dialysis as covariates. The antibody titer showed
an inverse trend with CA-IMT without statistical significance. oxidized LDL antibody was an independent predictor of
Conclusion. These results show for the first time that titer a low risk for cardiovascular mortality in ESRD patients.
of anti-oxLDL antibody is an independent factor inversely asso-
These results raise the possibility that antibody to oxi-ciated with arterial thickness in ESRD, supporting the concept
dized LDL has a protective role against atherosclerosisthat immunity against oxLDL plays an anti-atherogenic role.
in ESRD patients as well as in the healthy population.
The purpose of this study was to examine the relation-
ship between anti-oxidized LDL antibody titer and arte-Oxidized low-density lipoprotein (LDL) plays a cen-
tral role in the development of atherosclerosis. LDL rial wall thickness in ESRD patients.
from the circulation enters the arterial wall and is oxi-
dized in the subendothelium. Oxidized LDL in the arte-
METHODSrial wall may be taken up by macrophages, resulting in
foam cell formation and fatty streak lesions, or it may Subjects
diffuse back into the circulation. So far, it is not well
The subjects were 103 nondiabetic ESRD patients
understood what factors regulate or affect the fate of
who were treated with maintenance hemodialysis in theoxidized LDL.
morning sessions. They were randomly selected from ourSince oxidized LDL is highly antigenic, immune re-
clinical database as those patients who had been mea-sponse to oxidized LDL may modulate the metabolism
sured for CA-IMT, FA-IMT, and serum anti-oxidized
LDL antibody all at the same time. The clinical charac-
Key words: hemodialysis, atherosclerosis, oxidized LDL, antibody. teristics are summarized in Table 1. This study was ap-
proved by the institutional ethical committee. 2003 by the International Society of Nephrology
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Table 1. Characteristics of the subjects
Male gender % 36
Smoking % 27
Age years 54.99.7
Systolic blood pressure mm Hg 14526
Diastolic blood pressure mm Hg 8315
Mean blood pressure mm Hg 10417
Non-HDL cholesterol mmol/L 3.330.94
HDL cholesterol mmol/L 1.010.29
Duration of hemodialysis years 8.55.6
Body mass index kg/m2 21.42.6
Serum albumin g/L 37.92.9
C-reactive protein mg/L 4.74.5
Serum calcium mg/dL 9.30.5
Serum phosphorus mg/dL 6.31.3
Calcium-phosphate product mg2/dL 2 58.212.5
Anti-oxidized LDL antibody mU/mL 387273
Data are shown for mean  SD for continuous variables and percentage for
prevalence.
Measurement of intima-media thickness
CA-IMT and FA-IMT were measured by high-resolu-
tion B-mode ultrasonography using a real-time ultraso-
nograph with a 10-MHz in-line Sectascanner, as described
previously [11]. We took the greatest thickness of intima-
media complex, including plaques, if any, as IMT for Fig. 1. Simple correlation between serum anti-oxidized LDL antibody
titer and FA-IMT in ESRD patients.analysis. The examination included approximately 4 cm
of the common carotid artery, the carotid bulb, and 1
cm each of the internal and external carotid arteries.
The femoral artery was examined distal to the inguinal
inverse association remained significant in multiple re-ligament at the site where the artery divides into the
gression analysis including age, gender, hypertension,superficial and the profound femoral arteries, and
dyslipidemia, smoking, and duration of dialysis (Table 2).scanned approximately 4 cm proximal and 1 cm distal
The antibody titer had an inverse trend with CA-IMTto the flow divider.
but it was not statistically significant.
Anti-oxidized LDL antibody and other measurements
Blood was drawn in the morning after an overnight DISCUSSION
fast of at least 12 hours before starting a dialysis ses- We found in the present study that anti-oxidized LDL
sion. Serum IgG-class anti-oxidized LDL antibody was antibody titer inversely correlated with FA-IMT, and
measured by ELISA using a commercially available kit that the antibody titer showed a similar trend with
(OLAB; Biomedica, Vienna, Austria), as previously de- CA-IMT. This is the first study that has examined the
scribed [7, 8]. Antibody titer was calculated by con-
relationship between anti-oxidized LDL antibody titer
structing a standard curve using the standards included
and thickness of arterial wall in patients with ESRD.
in the kit and expressed in the unit defined by the manu-
Some previous studies showed elevated titer of anti-facturer. Other measurements were by routine methods.
oxidized LDL antibody in ESRD patients [5] and in
those with advanced atherosclerosis [2–4]. Because oxi-Statistical methods
dized LDL is a causative factor of atherosclerosis, theCorrelation between two variables was evaluated by
raised antibody titer was believed to mirror the increasedsimple regression analysis. Independent association be-
oxidized LDL in vivo and, therefore, an atherogenictween variables was assessed by multiple regression anal-
condition. However, in later studies, anti-oxidized LDLysis. P values less than 0.05 were considered statistically
antibody inversely correlated with plasma oxidized LDLsignificant.
concentration [7], CA-IMT [8], and FA-IMT [9] in the
healthy population. The present study has confirmed the
RESULTS inverse association of anti-oxidized LDL antibody titer
with FA-IMT in ESRD patients. Although the correla-Serum anti-oxidized LDL antibody showed a signifi-
cant and inverse correlation with FA-IMT (Fig. 1). The tion between the antibody titer and CA-IMT did not
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Table 2. Multiple regression analysis showing the association In conclusion, the present study revealed that anti-
between anti-oxidized LDL antibody titer and FA-IMT
oxidized LDL antibody was in an inverse association within 103 ESRD patients
arterial wall thickness in ESRD, suggesting the anti-
 value P value atherogenic role of antibody to oxidized LDL. Further
Age years 0.219 0.046 studies in ESRD are still needed to clarify the relation-
Male gender % 0.031 0.775 ship between oxidized LDL and the antibody levels, andSmoking % 0.012 0.909
the usefulness of plasma oxidized LDL concentration inMean blood pressure mm Hg 0.072 0.407
Non-HDL cholesterol mmol/L 0.126 0.205 cardiovascular risk assessment.
HDL cholesterol mmol/L 0.017 0.882
Duration of hemodialysis years 0.184 0.132 Reprint requests to Tetsuo Shoji, M.D., Ph.D., Department of Metab-
Body mass index kg/m2 0.109 0.275 olism, Endocrinology, and Molecular Medicine, Osaka City University
Serum albumin g/L 0.132 0.227 Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka
C-reactive protein mg/L 0.412 0.001 545-8585, Japan.
Calcium-phosphate product mg3/dL2 0.086 0.407 E-mail: t-shoji@med.osaka-cu.ac.jp
Anti-oxidized LDL antibody mU/mL 0.195 0.046
R 2 0.314 0.0007
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